12 Patents
- 0 cites
- 0 cites
- US121039312024Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
Beigene Switzerland GmbH
0 cites - 0 cites
- US119997432024Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
Beigene Switzerland GmbH
0 cites - US119705002024Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- Hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
Beigene Switzerland GmbH
0 cites - US118846742024Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- Hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
BEIGENE SWITZERLAND GmbH
0 cites - US118514372023Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
BEIGENE SWITZERLAND GmbH
0 cites - US118143892023Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
BEIGENE SWITZERLAND GmbH
0 cites - US117013572023Treatment of B Cell Cancers Using a Combination Comprising Btk Inhibitors
BEIGENE SWITZERLAND GmbH
0 cites - US115913402023Crystalline Form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- Hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, Preparation, and Uses Thereof
BEIGENE SWITZERLAND GmbH
0 cites